Greetings. Welcome to Leidos' Fourth Quarter Fiscal Year 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker, Stuart Davis from Investor Relations. Stuart, you may begin.

Thank you, operator, and good morning, everyone. I'd like to welcome you to our fourth quarter and fiscal year 2025 earnings conference call. Joining me today are Tom Bell, our CEO; and Chris Cage, our CFO. Today's call is being webcast on the Investor Relations portion of our website, where you'll also find the earnings release and supplemental financial presentation slides that we're using today. Turning to Slide 2 of the presentation, today's discussion contains forward-looking statements based on the environment as we currently see it, and as such, does include risks and uncertainties. Please refer to our press release for more information on the specific risk factors that could cause actual results to differ materially. Finally, as shown on Slide 3, we'll discuss GAAP and non-GAAP financial measures. A reconciliation between the 2 is included in today's press release and presentation slides. With that, let me turn the call over to Tom Bell, who will begin on Slide 4.

Thank you, Stuart, and good morning, everyone. I'm pleased you've been able to join us to discuss another strong quarter for Leidos, capping off an outstanding 2025. Of course, 2025 was a very dynamic year. The complexities of DOGE early and the longest U.S. government shutdown toward the end. But despite these challenges, we were able to deliver on our promises, importantly, first to our customers and, as a result, to our shareholders. We're pleased to have recorded 2025 revenue toward the top of our guidance and earnings and cash ended the year above our guidance. 2025 adjusted EBITDA margin was 14.1%, a year-over-year increase of 120 basis points. Non-GAAP diluted earnings per share grew by 17% and free cash flow grew by 26%. Q4 revenue was $4.2 billion, a year-over-year decrease of 3.6%, but normalized for the extra week in our fourth quarter of 2024 and the 6-week government shutdown in 2025, Q4 revenue would have grown approximately 4%. Chris will give you all the details on our financials later on this call. In addition to those financials, another significant highlight of our fourth quarter was net bookings of $5.6 billion, delivering a book-to-bill ratio of 1.3x. This matched the 1.3x book-to-bill ratio we also delivered in the third quarter of 2025. And our year-over-year funded backlog is up 15%. This momentum illustrates our NorthStar strategy's strong alignment with administration priorities and enduring trends. Let me mention a few of our key awards in the quarter. The Air Force awarded us a 5-year $2.2 billion contract to deploy Leidos' passive radar systems for base defense against fixed and rotary wing aircraft and cruise missiles. This award validates years of investment in our ALPS and MRADR systems that detect threats without emitting a signal. Our continued IRAD investment in this…

Thanks, Tom, and good morning, everyone. As Tom highlighted, 2025 was an outstanding year for Leidos, marking the third straight year of double-digit non-GAAP earnings and cash flow growth. We are focused on and delivering sustainable growth over the long term. Also, as Tom mentioned, despite external market pressures, performance exceeded initial projections across nearly all key metrics, enabling us to raise guidance twice this year and exceed the top end of our margin, earnings and cash flow ranges this quarter. Our performance stands as a testament to the strength of our differentiated portfolio, the precision of our NorthStar 2030 strategy and the discipline and agility of our entire team. Please turn to Slide 5. For the year, revenues of $17.2 billion were up 3.1%. For the quarter, revenues of $4.2 billion were down 3.6%. Year-over-year comparisons include the impact of 2 major factors: the 6-week government shutdown in 2025 and an extra work week in 2024 as part of our 4-4-5 financial calendar. These impacts were concentrated in the fourth quarters and the extra work week is about twice as impactful as the shutdown. Together, these 2 factors decreased revenue growth by about 7 percentage points for the quarter and 2 percentage points for the year. The underlying business grew strongly across the entire portfolio with especially robust demand in integrated air defense, intelligence community mission support, energy infrastructure and full-spectrum cyber. Adjusted EBITDA margin for the fourth quarter was 13.2%, up 160 basis points year-over-year. On a full year basis, adjusted EBITDA margin increased 120 basis points to 14.1%, exceeding the top end of our high 13s guidance from the last call. Our margin expansion journey has meaningfully changed how we view what is possible, and that change permeates the entire company. The sectors are more focused on…

[Operator Instructions] Our first question will come from the line of Seth Seifman with JPMorgan.

I wanted to ask, starting off, could you talk a little bit about the investment areas that you're expecting to put additional CapEx and the way that that supports, I assume, supports some of the ramp in the defense business? And to the extent that that may or may not be related to the co-investment opportunities you talked about with DoD?

Sure. Let me start by saying yes and we are investing in potential co-development opportunities with the Department of War, but it's not exclusively with the Department of War. The Department of Transportation, the FAA, has significant program opportunities, as I'm sure you are aware. And we are very keen on investing in our health business to ensure that we continue to accelerate away from the pack in that important business to Leidos. So, yes, as I said in my prepared remarks, Seth, we are negotiating several framework agreements with the Department of War when it comes to co-investment opportunities for exciting franchise programs for Leidos going forward. But that's not where all of that CapEx and all of that investment is going. We're investing in all the growth pillars now that we have a sound key strategy to grow this company into the future.

Yes, Seth, I mean, and just to dive a little deeper and certainly, in the defense area, that is the area that over the last few years, we've continued to ramp up our level of investment, and you're seeing the results of that with the increasing growth rates. Looking ahead to '26, certainly, our maritime growth pillar is an area where you'll see an expansion of some of our facility space there. What we're doing in Integrated Air Defense, the ABADS award is, again, a reinforcement that we have products that the government wants and how do we ramp up our production capacity, hypersonics, et cetera. So there's a number of programs there that will support that investment, and we're looking forward to realizing the returns on those.

Great. Great. And then maybe just as a quick follow-up, a little bit more model oriented. You talked about growth accelerating through the year, exiting double-digit or approaching a double-digit, so strong exit rate. But I guess the implication is much softer growth in the beginning of the year. Kind of how should we think about the early part of the year and which of the segments is seeing that weakness?

Yes, Seth. So I mean I think the pattern is right. I mean lower growth in the first half of the year, acceleration in the back half of the year. Some of the things that we've been talking about over the last several quarters, we haven't seen any significant money yet put towards some of the Golden Dome initiatives, the FAA modernization, et cetera, those are catalysts that can help propel the second half. We've got some new program wins that we'll be starting up. Tom talked about a couple of those. So you'll see that pattern increase in the back half of the year. And then we've got a very robust business development pipeline. Obviously, we're pleased with the 1.3x in Q4, back-to-back quarters of 1.3x book-to-bill and the team. That's despite the fact that we saw a lot of slippage into 2026 from the award pipeline. So you'll see some of those across a number of the business segments drive growth in the second half of next year.

Yes. And just to put a little added context on that, Seth, we saw about $7 billion in awards slipped from Q4 into this quarter. And our -- we have now $20 billion of pending awards and a $49 billion of backlog. So we have high proposal activity. Yes, there is a lag probably because of that long government shutdown we discussed in the fourth quarter. But we expect those awards to start coming in, and that will feed growth through the end of the year as those programs get on to execution.

[Operator Instructions] Our next question comes from the line of John Godyn with Citi.

I wanted to pick up on those last comments around book-to-bill. When I think of what we've seen from other services players, we've seen a dip and then an expectation of a bounce in book-to-bill. You guys have performed very well. So there's no dip. But despite that, it sounds like you still think that the award activity and the bookings backdrop is going to accelerate from here based on what you just said. And I was just hoping you can maybe elaborate on that and shed some additional color on what the shape of that might be through the year?

Thanks, John. Certainly, well, first of all, let's put this in context. We've been investing in our growth segment and our growth function for the better part of 2.5, 3 years now. We recognize that this was an area where we needed to make sure we had the best-in-class capabilities to help our customers understand how Leidos can make their solutions better, faster and cheaper. And so we've been investing in this function. We've brought in a lot of new leadership. And so the 1.3x book-to-bill ratio in both the third and fourth quarters of last year is no accident. It's no -- it's not happenstantial. It's the purposeful effect of a purposeful plan to invest in our growth function and then the manifestation of those efforts coming through the past. Yes, as I just said to Seth, we still see a robust pipeline, an order backlog, and we expect those orders to continue. We're very happy with both our recompete win rate and our takeaway win rate. And so we feel very good about the capacity we have built in our growth function and we expect that to continue to pay dividends.

Yes, John, I would only add that, I mean, looking at the trends here, the next 12-month pipeline of submittal activity is the highest point of the year in the fourth quarter. So we've seen that crescendo and looking at the percentage of activity, we expect the bulk of that, 3/4 of that to be geared towards new business and takeaway. So there is some recompete turf to protect, but that's again, like, we like to see a smaller percentage in next year's bid pipeline, and all of our segments have a robust number of opportunities that they're pursuing.

[Operator Instructions] Our next question comes from the line of Gautam Khanna with TD Cowen.

I wanted to just ask you about the VA medical exam recompete. What your expectations are for, how the terms might change? What you guys are doing to maybe sustain the profitability of it because typically recompetes, you got to sharpen the pencil. And any view on timing, any updates on that?

Sure. Well, first of all, we're very proud of Liz and Larry and the LQTC and Health business that we run. We've got a fantastic execution machine there that has helped our customer decreased backlog of veterans awaiting exams by almost 60%. And so we are very proud of what we've been able to do to serve that customer and serve this nation. Certainly, as we announced Health as being one of our growth pillars, we have no intention to see this market space despite, as Chris mentioned in his commentary, the entry of the fourth vendor and the possibility of a work share reallocation. That being said, we see volume continuing to go up. And therefore, we think we have everything to compete and win for to continue to serve our customers best and this nation's veterans best. We have, as we've said, 2 prime focuses for how we're going to grow our Health business. One is rural health transformation and the other is behavioral and integrated health exams and services. But on your specific question on the medical disability exams, we do see that in the middle of this year, we expect an RFP in a bid for the next phase of that program. Details at this point are pretty light about exactly what the customer is looking for, but we're actively engaged with them as we speak. And as we've been saying for a number of years now, we continue to invest differentially in our medical disability exam business to make sure that we can make sure veteran exams are done better, are done faster and are done less expensively for the Veterans Administration. And we expect those will be the 3 things that the Veteran Benefits Agency wants to see. They want to see costs come down. They want to see the number of veterans that get services go up and they want to see the efficiency and effectiveness of those exams be less mistake prone. And so that's everything we're focused on and what we expect to see. We'll update you as the year goes on. As we say, we expect a recompete and a bid somewhere in the summer, and we'll keep you very well informed on that. Chris, anything to add?

Just 2 quick points, Gautam, I would add. Number one, we just recompeted the program, and look at our performance, right? So we've proven that every time we can sharpen the pencil, we can deliver for the customer and for Leidos and our shareholders. Number two, if you go back to my prepared remarks, we kind of gave a horizon view in looking at Health beyond '26, robust profitability above 20%. That certainly contemplates how we envision this recompete unfolding over time, right? This is an area that we can sustain very attractive returns in and we're excited to demonstrate that.

[Operator Instructions] Our next question comes from the line of Colin Canfield with Cantor.

Maybe turning to the FY '26 growth guidance as well as margin. Perhaps if you could talk us through where you are forecasting the greatest degree of conservatism? And what are the key milestones that you need to see in order to lift both growth and margin guidance? And then essentially, as we think of that bridging into next year, is it fair to assume any outperformance of this year's guidance is a higher basis for next year? Or are there any kind of one-time things in nature that might pull in this year versus next year?

Yes. Colin, this is Chris. The conservatism, like the way you frame that. I mean there's certainly a lot of irons in the fire and a lot of make market opportunities that we're chasing. Clearly, defense has demonstrated a robust track record. That's probably the area that some decisions get made if a Beautiful Bill funding rolls out, Golden Dome activities accelerate, especially maritime, you could see that growth trend pick up more quickly. So there are some opportunities there that we're just monitoring. And then the FAA one, as Tom mentioned, the teams are ready to execute. We've put in very compelling offers to the customer. We've built demonstration ready capabilities. We are ready to go. So those things could be pulled forward and we could see some uplift. On the margin front, I think the commentary we just had on Health certainly is the area that we built into what we believe the business will be running at from a reduced volume and accommodated that. If that plays out a little differently, there could be some upside there. So we think we factored all that in. As it relates to one-timers, none of those are contemplated in this guide that we've rolled out. So as we deliver over the course of the year, I do believe that points the direction of how the momentum will carry into '27 and beyond for NorthStar 2030.

[Operator Instructions] Our next question is going to come from the line of Tobey Sommer with Truist.

In the sort of product and defense tech area, I was wondering if you could give us an update on the areas that you think have hit their stride with sort of programs of record and areas that are still developing that may demonstrate some progress here in '26 in that direction?

Yes, sure. Thank you, Tobey. Let's see. Well, first, let's start with IFPC. We were awarded a $4.1 billion IDIQ to ramp production, and that is going well. We have a target procurement of some 317 systems to be delivered by 2030. And we think that with the readying of the defense industrial base, FMS possibilities and, of course, Golden Dome, that is a very good bet for us to continue to grow. So we're very bullish on IFPC. You see the customer investing in a second interceptor that solidifies their seriousness of the system as a whole. And as the lead systems integrator for that, we sit in service to our customer to make sure that that system is all that they want it to be. Hypersonics was mentioned earlier. Obviously, the Department of War is fast tracking some 6 tech priorities to include scaled hypersonics. So that shows you that they're serious about it. And our recent awards of SLCM-N and JHTO OTAs, those mirror the Army's success of the Dark Eagle program. And so we're very happy with where that program is going from here. I mentioned in my prepared remarks, the ABADS award although we can't say much more about that. Again, Homeland Security and Base Defense are where those programs excel, and both of those things are very high priorities for the Department of War. Wide Field of View in the space area, we are very bullish on our opportunities to serve the space forces needs there. They are -- they have a budget climbing towards $40 billion, and we are a vital partner for the technical contributions across the Space Development Agency and all their tranches to date. So we've been accelerating internal investment there. The SDA's Tranche 0 mission has been successful, and…

Yes. Tobey, I'd only add, Tom had a robust list there and there's others. Maritime certainly is one of those areas with our CDAR product, ADC Mark V, what we're talking about with medium unmanned surface vessels. Those are the ones that have more runway and variants for the U.K. and Australia customer as well. So excited about the prospects in our maritime part of the portfolio there, too.

[Operator Instructions] Our next question will come from the line of Ken Herbert with RBC Capital Markets.

Maybe if you could address capital allocation. I think you said you'll be gross levered about 2.6x on a pro forma basis after ENTRUST. How are you thinking about incremental M&A opportunities this year? Where are your priorities? And what does the guidance imply for buybacks this year?

Yes, thanks. So first of all, again, this is a long arc that I think if you go back to the earnings calls past, I've transmitted pretty clearly that while we were searching for our growth strategy, we would have a capital deployment strategy that was very shareholder-friendly. We still have a rigorous return on investment capital analysis for any investment and any outflow of Leidos dollars, and we will continue to do that. But now with our NorthStar 2030 strategy in hand and we've been firmly in strategy execution mode, meeting the moment also of this administration, we are very well poised to deliver on and invest in those growth pillars that we've discussed. So we've increased investment over the last 3 years. We will continue to increase investment. And yes, inorganic and organic investments will be the lion's share of how we deploy our capital in the near term. That being said, we will continue to our dividend program, and we will look opportunistically for other shareholder-friendly deployments of capital as the need arises. Chris?

Yes. I mean, Ken, to get to your specific question on the repos, we haven't baked any into the guide that we gave you for this year. I mean, you can see that with ENTRUST coming online, there's a lot of capital going to that. But we have more capacity, and the priorities are what Tom laid out, and we'll monitor things as the year unfolds.

[Operator Instructions] Our next question comes from the line of Scott Mikus with Melius Research.

Tom, we've seen a lot of software stocks come under pressure year-to-date because of concerns that AI could drive down the cost for companies to develop software internally. We also hear from defense companies that AI will accelerate the shift towards outcome-based contracting. But are you concerned that AI could cause a race to the bottom on price, particularly for digital modernization programs?

Thanks. Yes, Scott, I see and hear and certainly see the stock market effect of the fear of AI overtaking the world and understand why some people might say that. But for us, the proliferation of AI isn't a threat, it's a force multiplier for everything we've always wanted to do. So we continue to lean into all commercial technologies. It is part of the business model that has made Leidos successful, and we don't see AI as being any different. We want to look at it, understand it, exploit it and be able to serve our customers with it no matter which model of AI, they want to embrace. That is why Will Johnson and our DigMod business embrace AI internally. We are very keen to make sure that we are the beta tester of how AI makes organizations faster and more efficient. And we expect that beta testing AI internally to Leidos will not only deliver bottom line results for us but also help us prototype and then deliver top line benefits for our customers as they seek to exploit AI to make their operations more efficient. So ultimately, we see AI as an opportunity to help our customers shift budgets away from maintenance and into high-value mission outcomes which is, of course, the business we're in, making their outcomes smarter and more efficient. I hope that helps, Scott.

Yes, it does. And then a quick question. You noted the backlog figures do not include anything from the Golden Dome IDIQ or the Microelectronics IDIQ. But does the guide assume that you will receive task orders this year that would convert to revenue? Or is that purely upside to the guide?

Yes, we don't ever include IDIQs. We only include the task orders when they come in. Of course, our business development and our sectors all want to assume that they get task orders that deliver revenue and profit in the year, and that's what they hunt for every year.

And Scott, just, I mean, as with any annual guide that we put out, there always is some element of new business that has to be won throughout the year, whether that comes from Golden Dome or comes from the robust number of other submittals that we have in the pipeline. It can be any number of those sources. But yes, if Golden Dome ramps up in any material way, we see upside from that.

Golden Dome, FAA, the Microelectronics, all of them. There's a ton of opportunities out there where we're poised to exploit over the coming months.

[Operator Instructions] Our next question will be from the line of Jonathan Siegmann with Stifel.

You've highlighted maritime as an area that could be potential for this year incrementally. Just can you talk a little bit about where the government is and the progress in identifying programs and when we might expect to actually hear something on some of these?

Yes. Thank you. Yes, the Department of Navy has a well-understood and publicized MUSV program for a large quantity of medium unmanned surface vehicles. We have had robust dialogue with the Department of the Navy and INDOPACOM, the combatant commanders who want to have this capability. And what we are actually talking about, Jonathan, is not only how we can help make sure that there are vessels built but the critical key sauce for Leidos that we've been talking and has been exciting customers greatly is the payload and mission packages that makes those vessels effective in a war scenario. And so what our secret sauce is, is not only how we can partner with private equity and shipyards around the United States to either retrofit or new build unmanned surface vessels. Frankly, that's not hard. The hard part is how do you make those vessels effective in the battle of the future, what INDOPACOM and other combatant commanders are anxious about. And that's where Leidos' long-term investments in our R&D, in C5ISR, in space really give us a differentiator in terms of how that vessel becomes effective for the combatant commander. Now, as far as timing, we are eager also. The dialogue in the Department of Navy is robust. We expect them to come forward with their firm plans soon, but we're still waiting. I hope that helps, Jonathan.

[Operator Instructions] Our next question comes from the line of Gavin Parsons with UBS.

I really appreciate all the guidance by segment. If I wrap all that up, can you hold and expand the mid-13% EBITDA margin beyond '26?

Yes. I think we dropped some breadcrumbs for you there, Gavin, to see that the best is yet to come on margins in our newly formed Homeland segment and certainly with additional upside in Defense. So those are the areas that I would point to on a longer-term horizon where we would expect some additional margin expansion opportunities. And clearly, we've talked a lot about Health today and the work that they've done, the great work that they've done to demonstrate the value they're bringing to the veterans agency. So the expectation is, yes, we're not done with margins, but consolidate the gains we've made, reprioritize, fund the critical investments for growth and then deliver exceptional results on that in '27 and beyond.

And don't negate the effects of our transformation office. We're very bullish about that being able to help Leidos become more efficient. And as a result, obviously, there could be some margin uplift there as our overheads come down. And as the year goes on, as we bring in ENTRUST, we expect that to be margin accretive. So we're very excited about the portfolio that's laying out for the year to come.

Operator, it looks like we have time for one more question.

[Operator Instructions] Our last question will come from the line of Greg Konrad with Jefferies.

Just wanted to follow up on the investment conversation. I mean, you talked about 3x CapEx in '26 and continuing to increase investment. I mean, how do you think about that stepping up beyond this year? How much of that is kind of in backlog and scaling versus future decisions? And then with that, how do you think about cash-on-cash returns because with some of these deals, we've seen better working capital offset those investments?

Yes, Greg, so I mean we haven't mapped out the '27 and beyond yet. I mean, clearly, the items we're investing in this year are to scale up, for the most part, scale-up capabilities that are in hand, programs that we're executing on or see clear line of sight demand for expansion, and we're finding ways to accommodate a higher ramp up on those than perhaps was previously contemplated. And you're right, as you think about with any investment outlay that we make, clearly, how do we get cash back in the door to make the cash-on-cash return more attractive. ENTRUST will be an example of that. How do we bring cash in from that business more rapidly, find ways to optimize their working capital performance. I think that's a strength of Leidos and an area that Tom alluded to, our transformation office, one of the initial things they're going to be taking on are ways that we can look to even streamline our DSO process. And if we could take a day or 2 out of there, that really moves the needle for Leidos. So we're going to be focused on that heavily. We're going to be looking to realize attractive returns on all the investments we make. But I don't think that you would say the $350 million of CapEx is the new normal going beyond this year. It was situation-dependent. We have the capacity to do that if the business case is there, but not necessarily what we see on an enduring basis.

And I would now like to hand the conference back over to Stuart Davis for closing remarks.

Operator, I appreciate your assistance on this morning's call, and thank you all for tuning in this morning and your interest in Leidos. We look forward to updating you again soon. Have a great day.

This concludes today's conference call. Thank you for participating, and you may now disconnect.